Skip to Main Content

Paper Details

FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.
Cancer Res
6
2022
Author NameAffiliation
Kristine PeltonDana-Farber Cancer Institute, Harvard Medical School
Maria TsoliChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales
David S ZieglerChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales
David S ZieglerKids Cancer Centre, Sydney Children's Hospital
David S ZieglerUniversity of New South Wales
Uta DirksenWest German Cancer Center, University Hospital Essen
Uta Dirksen
Uta DirksenWest German Cancer Center, University Hospital Essen
Uta Dirksen
Natalie J??gerHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) Heidelberg
Natalie J??ger
Natalie J??gerGerman Cancer Research Center (DKFZ)
Natalie J??gerHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) Heidelberg
Natalie J??gerGerman Cancer Research Center (DKFZ)
Natalie J??ger
Gnana Prakash BalasubramanianHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) Heidelberg
Gnana Prakash BalasubramanianGerman Cancer Research Center (DKFZ)
Christof M KrammUniversity Medical Center Gottingen
Michaela Nathrath
Michaela NathrathChildren's Cancer Research Centre and Department of Pediatrics, Technische Universitat Munchen
Stefan S BielackUniversity Hospital Stuttgart
Suzanne J BakerSt. Jude Children's Research Hospital
Jinghui ZhangSt. Jude Children's Research Hospital
Jinghui ZhangSt. Jude Children's Research Hospital
Gad GetzBroad Institute of MIT and Harvard
Gad GetzCenter for Cancer Research, Massachusetts General Hospital
Gad GetzMassachusetts General Hospital
Gad GetzHarvard Medical School
Gad GetzBroad Institute of MIT and Harvard
Gad GetzHarvard Medical School
Gad GetzMassachusetts General Hospital
Gad GetzCenter for Cancer Research, Massachusetts General Hospital
François AguetBroad Institute of MIT and Harvard
Nada JabadoMcGill University
Nada JabadoMcGill University, and The Research Institute of the McGill University Health Centre
Nada JabadoMcGill University
Nada JabadoMcGill University, and The Research Institute of the McGill University Health Centre
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) Heidelberg
Olaf WittNational Center for Tumor Disease (NCT) Network
Olaf WittHeidelberg University Hospital
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Olaf Witt
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) Heidelberg
Olaf Witt
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Olaf WittHeidelberg University Hospital
Olaf WittNational Center for Tumor Disease (NCT) Network
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) Heidelberg
Stefan M PfisterNational Center for Tumor Disease (NCT) Network
Stefan M PfisterHeidelberg University Hospital
  • 1 - 50

Datasets